Nanoemulsion Technology

Newport Beach, CA. February 18, 2019: The global nanoemulsion industry is witnessing high competition due to presence of several players, observes Transparency Market Research (TMR).

Some of the prominent players operating in the global technology for nanoemulsion are Mitsubishi Tanabe Pharma Corporation, GlaxoSmithKline plc, Sanofi, Novartis AG, AbbVie Inc., Allergan plc, AstraZeneca Inc., Kaken Pharmaceutical Co., Ltd., Fresenius Kabi AG, and B. Braun Melsungen AG. These companies are increasingly investing on research and development activities for launch of advanced nanoemulsion products, such as the massive worldwide growth market of cannabidiols and other hemp derived products.

The revenue of the global nanoemulsion market was registered in 2016 at the value of US $6.78 billion and expected to grow with the CAGR of 9.2% over the forecast period and attain the value of US $14.91 billion by the end of 2025. The NSAIDs is expected to attain revenue of US $2.470 billion due to the increasing usage nanoemulsion formulation in topical, serums and other forms of drugs and its route of administration for efficiency. On the basis of region, North America accounted for the larger share of about 39.7% in 2016. This growth of the region is attributable to increasing demand from mature pharmaceutical and biotechnology market and increasing research activities in the region.

Increasing Awareness about Chronic Diseases and Availability of Treatments

Nanoemulsion are able to dissolve large amount of hydrophobics coupled with ability of protecting drugs from processes such as hydrolysis and enzymatic degradation make them ideal carrier.  The several advantages of nanoemulsion over conventional emulsion including micro-droplet size of nanoemulsion with higher efficiency as a better carrier. The aforementioned factors are driving growth of the global nanoemulsion market.

Request A Sample:

The factors such as rapid technological advances in the field of pharmaceuticals and biotechnology industry, increasing awareness about chronic diseases and availability of treatments are positively influencing growth of the global nanoemulsion market. Additionally, numerous government policies favoring the target specific drugs delivery systems are boosting adoption of target specific drug delivery systems which is fueling growth of the global nanoemulsion market. Launch of technologically advanced products to meet the demand for efficient drug delivery systems is positively impacting on a growth of the global nanoemulsion market.

High Demand from Personal Care Industry to Drive Demand

Increasing healthcare facilities mainly in the developing countries, increasing economic stability, and increasing contribution of key players in in developing economies such as Latin America, Asia Pacific, and the Middle East and Africa. This is propelling growth of the global nanoemulsion market.

However, manufacturing cost of nanoemulsion are restraining growth of the global nanoemulsion market. Nevertheless, other advancements such as the no effects of flocculation and sedimentation, and non-toxic nature makes them suitable to be used in beauty products and baby-care products such as creams and lotions. The adoption from personal care industry has created lucrative opportunities for key players in the global nanoemulsion market for growth and high revenue generation.

This information is comprised in the new report by TMR, titled “Nanoemulsion Market (Drug Class – Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, and Vasodilators; Route of Administration – Topical, Oral, Parenteral, and Nasal; Distribution Channel – Hospital Pharmacies, Retail Pharmacies, and E-commerce) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.”

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

“This is proof that we made the right decision for our customers by presenting them with a better alternative than the typical CBD oil or isolate versions which are the most commonly sold. In addition, our customers can feel confident that they have purchased a quality, potent and affordable product that they can rely on.” says Johnny Drummond – Founder & CEO of Cannologies, Inc., parent company of the INFUZIONTM  brand of CBD products.


Sean Renninger

Shareholder Relations, LLC.

Direct: 310-775-1669